D. Ponard

The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins

Optimal Dissociation Methods Differ for N - and O -Glycopeptides

Autoimmune Complications of Chronic Lymphocytic Leukemia

Cellular pathophysiology of ischemic acute kidney injury

Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema

Complement as a diagnostic tool in immunopathology

Complement in human diseases: Lessons from complement deficiencies

Diagnostics for the developing world

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases

Complement: a key system for immune surveillance and homeostasis

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Delivery technologies for cancer immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Discrimination between host and pathogens by the complement system

A novel, complement-mediated way to enhance the interplay between macrophages, dendritic cells and T lymphocytes

Revealing the human mucinome

Rapid Diagnostic Tests for Malaria Parasites

N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation

Complement

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

The immunopathology of sepsis and potential therapeutic targets

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Keeping It All Going—Complement Meets Metabolism

Glycoproteomics

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Klebsiella pneumoniae: Going on the Offense with a Strong Defense

Complement System Part II: Role in Immunity

Point-of-Care Diagnostics for Global Health

Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis

Streptococcal Siglec-like adhesins recognize different subsets of human plasma glycoproteins: implications for infective endocarditis

Metallopeptidase activities in hereditary angioedema: Effect of androgen prophylaxis on plasma aminopeptidase P

Diagnosis of malaria in non-endemic countries by the ParaSight-F test.

C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target

C1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema

C1 inhibitor function using contact‐phase proteases as target: evaluation of an innovative assay

Human C3 Deficiency Associated with Impairments in Dendritic Cell Differentiation, Memory B Cells, and Regulatory T Cells